Statement on mid-urethral slings

RANZCOG

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists

Updated
17 August 2023

RANZCOG supports the use of mid-urethral slings (MUS) in the surgical management of female stress urinary incontinence (SUI) by appropriately trained and credentialed surgeons, where women make well informed decision on this option.

RANZCOG has well evidenced and clear guidance for surgeons who undertake MUS surgery (RANZCOG Position Statement on MUS (2022). RANZCOG emphasises:

– Surgeons performing MUS (and other gynaecological procedures) should only operate within their capabilities and the scope within which they are credentialed.

– Patients must be given information to make choices on treatment, including benefits, risks and alternative treatment options including doing nothing. All women considering MUS should discuss and be provided with the patient guide Considering Surgical Mesh to Treat Stress Urinary Incontenance? (health.govt.nz) developed by the New Zealand Mesh Working Group

– Careful clinical consideration must be given to all MUS procedures and RANZCOG supports the use of multi-disciplinary teams to consider cases prior to a decision to proceed

RANZCOG understands the consumer concerns behind the recent call to suspend the implantation of vaginally-inserted mesh sling for stress urinary incontinence (SUI). RANZCOG acknowledges that some women have experienced significant harm from MUS surgery.

Female urinary incontinence is common and is often debilitating and can substantially reduce a woman’s quality of life. Non-surgical treatments such as pelvic floor exercises are helpful for some women however, for many women surgery is necessary to provide a more effective and enduring end to their symptoms.

Midurethral slings (MUS) were developed in the 1990’s to treat stress urinary incontinence, offering a significantly less invasive procedure. An extensive body of literature indicates that MUS surgery is a highly effective treatment for SUI, associated with less pain, shorter hospitalisation, faster return to usual activities, compared to historic options for treating SUI.

The limitation of the medical scientific literature and our local information systems is lack of long term follow up data. Issues related to surgical mesh have emerged as women have been empowered to speak up about their longer-term outcomes, clearly indicating the need for longer term monitoring of outcomes of surgical procedures.

Read RANZCOG’s full submission in response to the petition to suspend the implantation of mesh sling for stress urinary incontinence.

CATEGORIES
Advocacy Women’s health

LATEST NEWS

Advocacy 15 September 2023
RANZCOG & FARE webinar – The moments you spend with her matter: alcohol & pregnancy
RANZCOG and the Foundation for Alcohol Research and Education (FARE)…
Training 6 September 2023
Training updates
Read the latest updates relevant to your training program.
the College 23 August 2023
RANZCOG statement on Mackay Base Hospital
The suspension of Mackay Base Hospital as an accredited training…
Aotearoa New Zealand 23 August 2023
Pause on using surgical mesh in Aotearoa New Zealand
On 23 August 2023, Director-General of Health Dr Diana Sarfati…
Aotearoa New Zealand 23 August 2023
RANZCOG statement on pause on using surgical mesh
RANZCOG notes today’s recommendation by the Director- General of Health.
Our Members 14 August 2023
2023 RANZCOG Honours winners
Congratulations to all the 2022 RANZCOG Honours winners.
Our Members 3 August 2023
RANZCOG Organisational Values Awards 2023 Recipients
Congratulations to those who have received RANZCOG Organisational Values Awards…